Efficacy and Safety of Digital Single-Operator Cholangioscopy in the Diagnosis of Indeterminate Biliary Strictures by Targeted Biopsies: A Systematic Review and Meta-Analysis

Li-Jia Wen,Jun-Hong Chen,Hong-Ji Xu,Qiong Yu,Kai Liu
DOI: https://doi.org/10.3390/diagnostics10090666
IF: 3.6
2020-09-02
Diagnostics
Abstract:Background: Biliary strictures are frequently encountered in clinical practice. The determination of their nature is often difficult. This study aims to systematically evaluate the efficacy and safety of the second generation of digital single-operator cholangioscopy (SpyGlass DS, DSOC) in indeterminate biliary strictures (IBDS) through biopsies. Methods: All relative studies published in Medline, the Cochrane Library, Web of Science, and EMBASE were included. The diagnostic tests for IBDS were compared to the surgical histology, autopsy, or long-term clinical follow-up. The methodological quality of the included studies was evaluated by the Quality Assessment of Studies of Diagnostic Accuracy Included in Systematic Reviews (QUADAS-2). Results: A total of 11 studies, which involved 356 patients diagnosed through biopsies, were included. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio were 0.74 (95% CI: 0.67–0.80), 0.98 (95% CI: 0.95–1.00), 10.52 (95% CI: 5.45–20.32), 0.31 (95% CI: 0.23–0.41), and 65.18 (95% CI: 26.79–158.61), respectively. The area under the curve (AUC) was 0.9479, and the pooled adverse event rate was 7%. The sensitivity and specificity in the heterogeneity analysis were I2 = 48.1% and I2 = 25.4%, respectively. Conclusion: SpyGlass DS is a safe and effective technique for IBDS. However, future randomized trials are needed to determine optimal number of biopsies.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the effectiveness and safety of Digital Single - Operator Cholangioscopy (DSOC) in the diagnosis of Indeterminate Biliary Strictures (IBDS) through biopsy. Specifically, the study aims to systematically evaluate the effectiveness and safety of the second - generation Digital Single - Operator Cholangioscopy (SpyGlass DS, DSOC) in the diagnosis of patients with IBDS through targeted biopsy. ### Research Background Biliary strictures are common in clinical practice, and it is often challenging to determine their nature. In particular, when routine laboratory tests, imaging studies, and tissue biopsies guided by endoscopic retrograde cholangiopancreatography (ERCP) cannot make a definite diagnosis, such strictures are called Indeterminate Biliary Strictures (IBDS). Although traditional ERCP combined with standard brush cytology and forceps biopsy are commonly used, their sensitivity to IBDS is less than 60% and the false - negative rate is relatively high. Therefore, it is particularly important to find more effective diagnostic methods. ### Research Objectives This article evaluates the effectiveness and safety of DSOC in the diagnosis of IBDS, especially through biopsy, through systematic review and Meta - analysis. The main objectives of the study include: 1. **Evaluate the diagnostic accuracy of DSOC**: including sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio. 2. **Evaluate the safety of DSOC**: including the incidence and types of adverse events. ### Methods The research team searched relevant literatures in the Medline, Cochrane Library, Web of Science, and EMBASE databases from 2015 (the time when SpyGlass DS was first introduced) to April 2020. The inclusion criteria include: - Original studies, including patients with IBDS evaluated by DSOC. - Using surgical pathology, autopsy, or long - term clinical follow - up as the gold standard. - Studies including at least 10 patients. ### Results Finally, 11 studies were included, involving a total of 356 patients. The main results are as follows: - **Diagnostic Accuracy**: - Pooled sensitivity: 0.74 (95% CI: 0.67 - 0.80) - Pooled specificity: 0.98 (95% CI: 0.95 - 1.00) - Positive likelihood ratio: 10.52 (95% CI: 5.45 - 20.32) - Negative likelihood ratio: 0.31 (95% CI: 0.23 - 0.41) - Diagnostic odds ratio: 65.18 (95% CI: 26.79 - 158.61) - Area under the ROC curve (AUC): 0.9479 - **Safety**: - Pooled adverse event incidence: 7% (95% CI: 3 - 12%) - Major complications include postoperative ERCP pancreatitis, cholangitis, bleeding, and perforation, among which acute cholangitis is the most common complication (1.8%; 95% CI: 0.8 - 3.1%). ### Conclusions The research results show that SpyGlass DS is a safe and effective technique for the diagnosis of IBDS. However, more randomized controlled trials are still needed in the future to determine the optimal number of biopsies. In addition, the study also found that an adequate number of biopsies is crucial for accurate diagnosis. ### Formula Representation - Sensitivity: \[ \text{Sensitivity}=\frac{\text{TP}}{\text{TP}+\text{FN}} \] - Specificity: \[ \text{Specificity}=\frac{\text{TN}}{\text{TN}+\text{FP}} \] - Positive Likelihood Ratio (PLR): \[ \text{PLR}=\frac{\text{Sensitivity}}{1 - \text{Specificity}} \] - Negative Likelihood Ratio (Negative Li